Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003607557 | SCV004551674 | pathogenic | Ataxia-telangiectasia syndrome | 2023-11-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln852Profs*8) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with breast cancer (PMID: 30287823). ClinVar contains an entry for this variant (Variation ID: 1801584). For these reasons, this variant has been classified as Pathogenic. |
Laboratory for Genotyping Development, |
RCV003164619 | SCV002758287 | pathogenic | Gastric cancer | 2021-07-01 | no assertion criteria provided | research |